Cognex (CGNX) director adds 2,913 shares through Restricted Stock Unit conversion

Rhea-AI Filing Summary

Cognex Corp director Dianne M. Parrotte increased her direct ownership through an equity award event. On February 21, 2026, she exercised or converted 2,913 Restricted Stock Units into 2,913 shares of Cognex common stock at a stated price of $0.0000 per share, indicating no cash outlay in this transaction. Following the conversion, her directly held common stock position rose to 33,431 shares. The filing also reports outstanding Non-Qualified Stock Options with direct ownership covering 7,500, 18,400, and 18,100 shares, which remain as rights to buy stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PARROTTE DIANNE M

(Last) (First) (Middle)

ONE VISION DRIVE

(Street)

NATICK MA 01760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNEX CORP [ CGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/21/2026		M		2,913	A	$0.0	33,431	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0.0(1)	02/21/2026		M			2,913	02/21/2024(2)	02/21/2026	Common Stock	2,913	$0.0	0	D
Non-Qualified Stock Option (right to buy)	$45.06							05/02/2019	05/02/2028	Common Stock	7,500		7,500	D
Non-Qualified Stock Option (right to buy)	$50.94							02/18/2021	02/18/2030	Common Stock	18,400		18,400	D
Non-Qualified Stock Option (right to buy)	$51.49							02/19/2020	02/19/2029	Common Stock	18,100		18,100	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.

2. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.

	Dianne M. Parrotte	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cognex (CGNX) director Dianne Parrotte report?

Cognex director Dianne M. Parrotte reported exercising or converting 2,913 Restricted Stock Units into 2,913 shares of common stock. This award-related transaction increased her direct share holdings and did not involve an open-market purchase or sale.

How many Cognex (CGNX) shares does Dianne Parrotte hold after this Form 4?

After the reported transactions, Dianne M. Parrotte directly holds 33,431 shares of Cognex common stock. This reflects the addition of 2,913 shares received from the exercise or conversion of Restricted Stock Units disclosed in the filing.

Were any Cognex (CGNX) shares sold in Dianne Parrotte’s Form 4 filing?

The Form 4 does not report any sales by Dianne M. Parrotte. It shows an exercise or conversion of 2,913 Restricted Stock Units into common shares, which increased her direct holdings without recording a disposition transaction.

What equity awards or options does Dianne Parrotte have in Cognex (CGNX)?

The filing lists Non-Qualified Stock Options with direct ownership levels of 7,500, 18,400, and 18,100 underlying shares. These options are rights to buy Cognex common stock and remain outstanding after the reported RSU conversion.

How were the Restricted Stock Units described in the Cognex (CGNX) Form 4 footnotes?

The footnotes state that each Restricted Stock Unit represents a contingent right to receive one share of Cognex common stock. They also describe vesting in three tranches on the first, second, and third anniversaries of the February 21, 2023 grant date.

Did Dianne Parrotte pay cash to acquire Cognex (CGNX) shares in this Form 4?

The reported price per share for the RSU-related common stock is shown as 0.0000, indicating no cash purchase price. The shares were acquired through exercise or conversion of equity awards rather than an open-market cash transaction.